Latest Piperazines Stories
WILMINGTON, Del., Dec. 19, 2014 /PRNewswire/ -- AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved LYNPARZA(TM) (olaparib) capsules.
HPPI to commence Phase IIb study in first quarter 2015 of SUBA(TM)-Itraconazole for treatment of basal cell carcinoma in patients with basal cell carcinoma nevus syndrome TAMPA, Fla.
Geodon's drug label has been modified to warn of drug reactions with eosinophilia and systemic symptoms (DRESS); patients taking Geodon experiencing a fever with a rash and/or swollen lymph
DUBLIN, Dec. 15, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it is filing an emergency appeal to the U.S.
MOUNTAIN VIEW, Calif. and BARCELONA, Spain, Dec. 11, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) and Grupo Ferrer Internacional, S.A.
- Fewer patients on Tasigna vs. Gleevec had their leukemia progress to advanced stage, a key goal of treatment in CML and important clinical benefit (1) EAST HANOVER, N.J., Dec.
SAN FRANCISCO, Dec.
LONDON, Nov. 27, 2014 /PRNewswire/ -- INTRODUCTIONTargeted therapeutics is fast emerging as the key focus area in biopharmaceutical industry.
RnRMarketResearch.com adds “Market Research Report on Global and Chinese Olaparib (CAS 763113-22-0) Industry, 2009-2019” Latest Report to its store. Dallas,
- a meat pie that is usually eaten at Christmas in Quebec